Keras/TensorFlow in Drug Design for Immunity Disorders
P. Dragan, K. Joshi, A. Atzei, D. Latek
This study uses Keras/TensorFlow to enhance structure-based virtual screening for drug discovery targeting chemokine receptors, showing improved prediction of receptor subtype selectivity.
bioRxiv · Sep 14, 2023 · PreprintImmunology